デフォルト表紙
市場調査レポート
商品コード
1632598

医療機器用電極の世界市場:市場規模・シェア・動向分析 (種類別・地域別・セグメント別、2025年~2030年)

Electrodes For Medical Devices Market Size, Share & Trends Analysis Report By Type (Diagnostics (Electrocardiogram, Electroencephalogram, Electromyogram), Therapeutics), By Region (North America, Europe, APAC), And Segment Forecasts, 2025 - 2030


出版日
ページ情報
英文 130 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
医療機器用電極の世界市場:市場規模・シェア・動向分析 (種類別・地域別・セグメント別、2025年~2030年)
出版日: 2024年12月24日
発行: Grand View Research
ページ情報: 英文 130 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医療機器用電極市場の成長と動向:

Grand View Research社の最新レポートによると、世界の医療機器用電極の市場規模は、2030年までに27億米ドルに達すると予測されています。

同市場は2025年から2030年にかけてCAGR 6.5%で成長すると予測されています。同市場は、心臓病、パーキンソン病 (PD)、アルツハイマー病、脳疾患、三叉神経痛 (TNまたはTGN)、副鼻腔炎、耳鳴り、レイノー病、線維筋痛症、循環障害、痛風、体の痛みなどの慢性疾患やその他の疾患の有病率が世界中で増加していることから、予測期間中に有利な成長が見込まれます。

最小侵襲手術 (MIS) は、腹腔鏡、内視鏡、関節鏡、その他の外科手術のために体に小さな切開を加える医療技術の進歩のひとつです。この手術は、回復が早く、術後の感染症や痛み、大出血が少なく、瘢痕が少なく、精度が高いという利点から人気を集めています。2015年には、2,000万人以上の米国人がMISを受けており、予測期間中にこの分野の成長を支援すると期待されています。

医療機器用電極市場:分析概要

  • 診断分野が2024年の市場を独占しています。ここ数年、心血管疾患、神経疾患、睡眠障害が増加しており、世界中で実施される診断処置の数が増加しています。
  • 心臓疾患、胎児性苦痛症候群、眼疾患、神経疾患の有病率の上昇により、心電図 (ECG)、脳波 (EEG)、電気外科、胎児頭皮電極が広く使用されています。
  • 治療分野では、予測期間中に最も速いCAGRで成長すると予測されています。治療分野はさらに、ペースメーカー、経皮的電気神経刺激装置 (TENS)、除細動器、電気手術、その他に分類されます。
  • 除細動器と電気手術用電極は、予測期間中にかなりの市場シェアを占めると予測されています。これは、装着者の心臓リズムを常時監視し、異常の発生を特定してユーザーに通知し、正常な心臓機能を回復させるウェアラブル除細動器の開発が進んでいるためです。
  • 北米は、同地域におけるCVDの有病率の増加、個人のライフスタイルの変化、人々の健康意識、米国とカナダにおけるターゲット層の存在により、2024年に42.8%の最大の収益シェアを占めました。
  • アジア太平洋地域は予測期間中に12.7%のCAGRで最速の成長が見込まれます。これは、同地域における慢性疾患の存在、健康意識に関する政府の取り組み、医療分野への投資の急増に起因しています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 医療機器用電極市場:変動要因・傾向・範囲

  • 市場連関の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因の分析
  • 医療機器用電極市場:分析ツール
    • 業界分析:ポーターのファイブフォース分析
    • PESTEL分析

第4章 医療機器用電極市場:種類別の推定と動向分析

  • 世界の医療機器用電極市場:種類別のダッシュボード
  • 世界の医療機器用電極市場:種類別の変動分析
  • 世界の医療機器用電極市場:種類別 (収益ベース)
  • 診断用
    • 心電図 (ECG)
    • 脳波 (EEG)
    • 筋電図 (EMG)
    • 網膜電図 (ERG)
    • 胎児の頭皮
    • その他
  • 治療用
    • ペースメーカー
    • 経皮電気神経刺激装置
    • 除細動器
    • 電気手術
    • その他

第5章 医療機器用電極市場:地域別の推定・動向分析

  • 地域別のダッシュボード
  • 市場規模の予測と動向分析 (2018~2030年)
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 企業/競合の分類
  • ベンダー情勢
    • 主要企業の市場シェア分析 (2024年)
    • 3M
    • Boston Scientific Corporation
    • GE Healthcare
    • CONMED Corporation
    • Medtronic
    • Natus Medical Incorporated
    • Thermo Fisher Scientific Inc.
    • Koninklijke Philips NV
    • X-trodes
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America electrodes for medical devices market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 4 U.S. electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 5 Canada electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 6 Mexico electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 7 Europe electrodes for medical devices market, by region, 2018 - 2030 (USD Million)
  • Table 8 Europe electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 9 Germany electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 10 UK electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 11 France electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 12 Italy electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 13 Spain electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 14 Denmark electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 15 Sweden electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 16 Norway electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific electrodes for medical devices market, by region, 2018 - 2030 (USD Million)
  • Table 18 Asia Pacific electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 19 China electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 20 Japan electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 21 India electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 22 South Korea electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 23 Australia electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 24 Thailand electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 25 Latin America electrodes for medical devices market, by region, 2018 - 2030 (USD Million)
  • Table 26 Latin America electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 27 Brazil electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 28 Argentina electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 29 MEA electrodes for medical devices market, by region, 2018 - 2030 (USD Million)
  • Table 30 MEA electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 31 South Africa electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 33 UAE electrodes for medical devices market, by type, 2018 - 2030 (USD Million)
  • Table 34 Kuwait electrodes for medical devices market, by type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market research approaches
  • Fig. 4 QFD modeling for market share assessment
  • Fig. 5 Market formulation & validation
  • Fig. 6 Electrodes for medical devices market: market outlook
  • Fig. 7 Electrodes for medical devices competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 Related/ancillary market outlook
  • Fig. 10 Electrodes for medical devices market driver impact
  • Fig. 11 Electrodes for medical devices market restraint impact
  • Fig. 12 Electrodes for medical devices market: Type movement analysis
  • Fig. 13 Electrodes for medical devices market: Type outlook and key takeaways
  • Fig. 14 Diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Electrocardiogram (ECG) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Electroencephalogram (EEG) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Electromyogram (EMG) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Electroretinogram (ERG) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Fetal scalp market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Therapeutics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Pacemaker market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Transcutaneous electrical nerve stimulator (TENS) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Defibrillator market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Electrosurgical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Global electrodes for medical devices market: Regional movement analysis
  • Fig. 28 Global electrodes for medical devices market: Regional outlook and key takeaways
  • Fig. 29 Global electrodes for medical devices market share and leading players
  • Fig. 30 North America, by country
  • Fig. 31 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. key country dynamics
  • Fig. 33 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Canada key country dynamics
  • Fig. 35 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Mexico key country dynamics
  • Fig. 37 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 UK key country dynamics
  • Fig. 40 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Germany key country dynamics
  • Fig. 42 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 France key country dynamics
  • Fig. 44 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Italy key country dynamics
  • Fig. 46 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Spain key country dynamics
  • Fig. 48 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark key country dynamics
  • Fig. 50 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden key country dynamics
  • Fig. 52 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Norway key country dynamics
  • Fig. 54 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 China key country dynamics
  • Fig. 57 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Japan key country dynamics
  • Fig. 59 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 India key country dynamics
  • Fig. 61 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Thailand key country dynamics
  • Fig. 63 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea key country dynamics
  • Fig. 65 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Australia key country dynamics
  • Fig. 67 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Brazil key country dynamics
  • Fig. 70 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Argentina key country dynamics
  • Fig. 72 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 South Africa key country dynamics
  • Fig. 75 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Saudi Arabia key country dynamics
  • Fig. 77 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 UAE key country dynamics
  • Fig. 79 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Kuwait key country dynamics
  • Fig. 81 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Market share of key market players- Electrodes for medical devices market
目次
Product Code: GVR-1-68038-913-5

Electrodes For Medical Devices Market Growth & Trends:

The global electrodes for medical devices market size is anticipated to reach USD 2.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 6.5% from 2025 to 2030. The market is anticipated to witness lucrative growth during the forecast period, owing to increasing prevalence of chronic and other diseases such as heart diseases, Parkinson's Disease (PD), Alzheimer's disease, brain disorders, Trigeminal Neuralgia (TN or TGN), sinusitis, tinnitus, Raynaud's disease, fibromyalgia, circulatory disturbances, gout, and body ache, across the globe.

Minimally Invasive Surgery (MIS) is one of the advancements in medical technology in which small incisions are made in the body for laparoscopy, endoscopy, arthroscopy, and other surgical procedures. This procedure is gaining popularity owing to faster recovery, lesser postsurgical infections, pain, & major bleeding, reduced scarring, and high accuracy benefits. In 2015, over 20.0 million Americans underwent MIS, which is expected to assist in the growth of this vertical during the forecast period.

Electrodes For Medical Devices Market Report Highlights:

  • The diagnostics segment dominated the market in 2024. There has been an increase in the number of cardiovascular, neurological, and sleep disorders in the last few years, which has led to an increase in the number of diagnostics procedures being carried out around the world.
  • Rising prevalence of heart diseases, fetal distress syndrome, ocular diseases, and neurological disorders make extensive use of Electrocardiogram (ECG), Electroencephalogram (EEG), electrosurgical, and fetal scalp electrodes
  • The therapeutics segment is expected to grow at the fastest CAGR during the forecasted period. The therapeutics segment is further classified into pacemakers, Transcutaneous Electrical Nerve Stimulators (TENS), defibrillators, electrosurgical, and others.
  • Defibrillator and electrosurgical electrodes are projected to hold substantial market share over the forecast period. This can be attributed to the advanced development of wearable defibrillator that constantly monitors the cardiac rhythms of the wearer and identifies & notifies the user about the occurrence of any abnormality and helps regain the normal heart functionality
  • North America held the largest revenue share of 42.8% in 2024 due to the increasing prevalence of CVD in the region, the changing lifestyle of individuals, health awareness among people, and the presence of the target audience in the U.S. and Canada.
  • Asia Pacific is expected to grow at the fastest CAGR of 12.7% over the forecast period. This can be attributed to the presence of chronic diseases in the region, government initiatives regarding health awareness & surge in investment in the healthcare sector.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type scope
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Electrodes For Medical Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing demand for minimally invasive procedures.
      • 3.2.1.2. Rising prevalence of chronic cardiovascular diseases
      • 3.2.1.3. Technological advancements in electrode materials and designs
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of advanced electrodes and devices
      • 3.2.2.2. Stringent regulatory approval processes, delaying product launches
  • 3.3. Electrodes For Medical Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Electrodes For Medical Devices Market: Type Estimates & Trend Analysis

  • 4.1. Global Electrodes For Medical Devices Market: Type Dashboard
  • 4.2. Global Electrodes For Medical Devices Market: Type Movement Analysis
  • 4.3. Global Electrodes For Medical Devices Market by Type, Revenue
  • 4.4. Diagnostics
    • 4.4.1. Diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Electrocardiogram (ECG)
      • 4.4.2.1. Electrocardiogram (ECG) market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Electroencephalogram (EEG)
      • 4.4.3.1. Electroencephalogram (EEG) market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Electromyogram (EMG)
      • 4.4.4.1. Electromyogram (EMG) market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Electroretinogram (ERG)
      • 4.4.5.1. Electroretinogram (ERG) market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Fetal Scalp
      • 4.4.6.1. Fetal scalp market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.7. Others
      • 4.4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Therapeutics
    • 4.5.1. Therapeutics market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Pacemaker
      • 4.5.2.1. Pacemaker market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Transcutaneous electrical nerve stimulator
      • 4.5.3.1. Transcutaneous electrical nerve stimulator market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.4. Defibrillator
      • 4.5.4.1. Defibrillator market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.5. Electrosurgical
      • 4.5.5.1. Electrosurgical market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.6. Others
      • 4.5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Electrodes For Medical Devices Market: Regional Estimates & Trend Analysis by Type

  • 5.1. Regional Dashboard
  • 5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.3. North America
    • 5.3.1. U.S.
      • 5.3.1.1. Key country dynamics
      • 5.3.1.2. Regulatory framework/ reimbursement structure
      • 5.3.1.3. Competitive scenario
      • 5.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.2. Canada
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Regulatory framework/ reimbursement structure
      • 5.3.2.3. Competitive scenario
      • 5.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3. Mexico
      • 5.3.3.1. Key country dynamics
      • 5.3.3.2. Regulatory framework/ reimbursement structure
      • 5.3.3.3. Competitive scenario
      • 5.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Key country dynamics
      • 5.4.1.2. Regulatory framework/ reimbursement structure
      • 5.4.1.3. Competitive scenario
      • 5.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. France
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Regulatory framework/ reimbursement structure
      • 5.4.4.3. Competitive scenario
      • 5.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Regulatory framework/ reimbursement structure
      • 5.4.5.3. Competitive scenario
      • 5.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.6. Norway
      • 5.4.6.1. Key country dynamics
      • 5.4.6.2. Regulatory framework/ reimbursement structure
      • 5.4.6.3. Competitive scenario
      • 5.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Key country dynamics
      • 5.4.7.2. Regulatory framework/ reimbursement structure
      • 5.4.7.3. Competitive scenario
      • 5.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Key country dynamics
      • 5.4.8.2. Regulatory framework/ reimbursement structure
      • 5.4.8.3. Competitive scenario
      • 5.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. China
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. India
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework/ reimbursement structure
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.5. South Korea
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework/ reimbursement structure
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework/ reimbursement structure
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Key country dynamics
      • 5.6.1.2. Regulatory framework/ reimbursement structure
      • 5.6.1.3. Competitive scenario
      • 5.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Argentina
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. South Africa
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework/ reimbursement structure
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework/ reimbursement structure
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework/ reimbursement structure
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company/Competition Categorization
  • 6.2. Vendor Landscape
    • 6.2.1. Key company market share analysis, 2024
    • 6.2.2. 3M
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Boston Scientific Corporation
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. GE Healthcare
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. CONMED Corporation
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Medtronic
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Natus Medical Incorporated
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Thermo Fisher Scientific Inc.
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Koninklijke Philips N.V.
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. X-trodes
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives